|
ELP4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.66453525910038E-15 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
5.160000E-01 |
| Stage1-vs-Stage3 |
1.352020E-02 |
| Stage1-vs-Stage4 |
6.796800E-04 |
| Stage2-vs-Stage3 |
3.992200E-02 |
| Stage2-vs-Stage4 |
6.924400E-03 |
| Stage3-vs-Stage4 |
3.420800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.58815191500616E-12 |
| Normal-vs-Asian |
1.62436730732907E-12 |
| Caucasian-vs-AfricanAmerican |
8.157000E-01 |
| Caucasian-vs-Asian |
9.802200E-01 |
| AfricanAmerican-vs-Asian |
8.446800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
3.092400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
2.30829999559035E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.955200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.290790E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.813000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.427200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.953600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.130400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.521510E-02 |
| Classical-VS-Follicular |
7.554200E-02 |
| Classical-VS-Other |
8.475800E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
9.229300E-04 |
| Tall-VS-Other |
2.988400E-01 |
| Tall-VS-Normal |
1.62436730732907E-12 |
| Follicular-VS-Other |
4.982200E-01 |
| Follicular-VS-Normal |
1.62436730732907E-12 |
| Other-VS-Normal |
1.28659999998337E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.026780E-01 |
|
|
